K Herrlinger

1.4k total citations · 1 hit paper
16 papers, 883 citations indexed

About

K Herrlinger is a scholar working on Genetics, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, K Herrlinger has authored 16 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 7 papers in Epidemiology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in K Herrlinger's work include Inflammatory Bowel Disease (12 papers), Microscopic Colitis (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). K Herrlinger is often cited by papers focused on Inflammatory Bowel Disease (12 papers), Microscopic Colitis (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). K Herrlinger collaborates with scholars based in Germany, United States and United Kingdom. K Herrlinger's co-authors include Klaus Fellermann, Eduard F. Stange, Matthias Schwab, Andreas Stallmach, Péter Fritz, Jan Wehkamp, Elke Schäffeler, J.‐M. Schröder, Michael Weichenthal and Miriam Schlee and has published in prestigious journals such as Gut, Clinical Pharmacology & Therapeutics and Alimentary Pharmacology & Therapeutics.

In The Last Decade

K Herrlinger

15 papers receiving 857 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression

2004 618 citations Jan Wehkamp, Jürgen Harder et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K Herrlinger Germany	7	484	300	287	250	210	16	883
Mira Baron United States	13	201 0.4×	238 0.8×	568 2.0×	131 0.5×	144 0.7×	17	1.2k
William J. Nadeau United States	6	253 0.5×	290 1.0×	131 0.5×	160 0.6×	125 0.6×	6	645
Per Brandtzaeg Norway	10	141 0.3×	498 1.7×	363 1.3×	118 0.5×	209 1.0×	12	1.1k
Alicia C Marín Spain	17	515 1.1×	290 1.0×	409 1.4×	172 0.7×	436 2.1×	46	1.2k
Robert P. McCabe United States	15	496 1.0×	416 1.4×	356 1.2×	173 0.7×	232 1.1×	34	1.0k
Bo Shen United States	12	291 0.6×	145 0.5×	209 0.7×	155 0.6×	389 1.9×	31	828
Ira Shafran United States	16	787 1.6×	293 1.0×	821 2.9×	172 0.7×	296 1.4×	44	1.2k
R Merilahti-Palo Finland	14	257 0.5×	238 0.8×	96 0.3×	150 0.6×	87 0.4×	19	954
Qinping Liao China	17	86 0.2×	154 0.5×	246 0.9×	228 0.9×	83 0.4×	65	992
Martine Baudin France	13	111 0.2×	256 0.9×	394 1.4×	126 0.5×	83 0.4×	25	750

Countries citing papers authored by K Herrlinger

Since Specialization

Citations

This map shows the geographic impact of K Herrlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Herrlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Herrlinger more than expected).

Fields of papers citing papers by K Herrlinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Herrlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Herrlinger. The network helps show where K Herrlinger may publish in the future.

Co-authorship network of co-authors of K Herrlinger

This figure shows the co-authorship network connecting the top 25 collaborators of K Herrlinger. A scholar is included among the top collaborators of K Herrlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Herrlinger. K Herrlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Dignaß, Axel, Daniel C. Baumgart, Hendrik Lehnert, et al.. (2015). Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues. Journal of Crohn s and Colitis. 10(1). 31–37. 13 indexed citations

Schmidt, Carsten, K Herrlinger, Britta Siegmund, et al.. (2014). Azathioprin in der Therapie des Morbus Crohn – eine Standortbestimmung vor dem Hintergrund aktueller Studien. Zeitschrift für Gastroenterologie. 52(12). 1423–1430. 2 indexed citations

Preiß, J., Bernd Bokemeyer, H. J. Buhr, et al.. (2014). Aktualisierte S3-Leitlinie – „Diagnostik und Therapie des Morbus Crohn“ 2014. Zeitschrift für Gastroenterologie. 52(12). 1431–1484. 100 indexed citations

Reinisch, Walter, Sieglinde Angelberger, Wolfgang Petritsch, et al.. (2013). P608 Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in Crohn's disease patients with endoscopic recurrence: follow-up data of a randomised, double-blind, double-dummy, 1-year, multicentre trial. Journal of Crohn s and Colitis. 7. S254–S254. 6 indexed citations

Herrlinger, K, Jörg Emmrich, H. Lehnert, et al.. (2012). Short‐term efficacy of tacrolimus in steroid‐refractory ulcerative colitis – experience in 130 patients. Alimentary Pharmacology & Therapeutics. 37(1). 129–136. 59 indexed citations

Herrlinger, K, Stefan Winter, Alexander Teml, et al.. (2011). ABCB1 Single-Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis. Clinical Pharmacology & Therapeutics. 89(3). 422–428. 39 indexed citations

Herrlinger, K. (2010). Einteilung und Management der oberen gastrointestinalen Blutung. Der Internist. 51(9). 1145–1158. 2 indexed citations

Herrlinger, K & EF Stange. (2010). Therapie des Morbus Crohn: Step-up oder Top-down?. DMW - Deutsche Medizinische Wochenschrift. 135(34/35). 1694–1698. 1 indexed citations

Angelberger, Sieglinde, Elke Schaeffeler, Alexander Teml, et al.. (2010). Relationship between Thiopurine metabolite levels and endoscopic improvement in patients with postoperative moderate to severe endoscopic recurrence of Crohn's disease. Zeitschrift für Gastroenterologie. 48(5). 2 indexed citations

10.

Herrlinger, K, Bianca M. Wittig, & Eduard F. Stange. (2009). Chronisch entzündliche Darmerkrankungen. Der Internist. 50(10). 1229–1248. 1 indexed citations

11.

Baburajan, Bijay, M Arenas, Natalie J. Prescott, et al.. (2007). The pharmacogenetics of folate and purine metabolic pathways in methotrexate therapy of inflammatory bowel disease.. Gut. 56. 1 indexed citations

12.

Baburajan, Bijay, Natalie J. Prescott, K Herrlinger, et al.. (2007). HLA-G 14BP insertion-deletion polymorphism influences response to methotrexate in inflammatory bowel disease.. Gut. 56. 1 indexed citations

13.

Wehkamp, Jan, Jürgen Harder, Michael Weichenthal, et al.. (2004). NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression. Gut. 53(11). 1658–1664. 618 indexed citations breakdown →

14.

Schwab, Matthias, K Herrlinger, Elke Schaeffeler, & EF Stange. (2003). Therapie chronisch entzündlicher Darmerkrankungen mit Azathioprin, 6-Mercaptopurin und 6-Thioguanin. DMW - Deutsche Medizinische Wochenschrift. 128(8). 378–385.

15.

Schwab, Matthias, K Herrlinger, Elke Schaeffeler, & Eduard F. Stange. (2003). Clinical pharmacology of azathioprine, 6-mercaptopurine and 6-thioguanine in the treatment of inflammatory bowel diseases. DMW - Deutsche Medizinische Wochenschrift. 128(8). 378–385. 1 indexed citations

16.

Herrlinger, K, Peter Deibert, Matthias Schwab, et al.. (2003). Remission maintenance by tioguanine in chronic active Crohn's disease. Alimentary Pharmacology & Therapeutics. 17(12). 1459–1464. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact